Final Melanoma Survival Data Headed to ESMO, Faron Confirms
Faron will present final melanoma survival data at the ESMO congress — a mature dataset that could shape advanced cutaneous melanoma conversations.
Topic
Clinical Trials
Topic
Clinical Trials
Evaxion Reports Three-Year Data for Melanoma Vaccine EVX-01
Evaxion reports three-year data for melanoma vaccine EVX-01, a personalized neoantigen candidate; the disclosure headline omits s…
Male and Female Skin Play by Different Rules, Scientists Find
Scientists report male and female skin follow different biological rules, a finding with implications for trial design, treatment…
Non-Steroidal Psoriasis Therapy Reports Symptom Reduction
A Drug Target Review brief reports a promising psoriasis therapy reducing symptoms without corticosteroids, but names no drug, no…
MD Anderson Survivor Profile Credits Immunotherapy Trial in Stage IV Melanoma
A Stage IV melanoma survivor credits an immunotherapy clinical trial at UT MD Anderson. The headline carries the message, the ful…
Itch Precedes Lesion Clearance in Prurigo Nodularis, 11-Trial Analysis Suggests
A landmark pooled analysis of 11 trials finds itch relief in prurigo nodularis precedes visible lesion healing, reframing treatme…
Intratumoral Immunotherapy for Skin Cancer: Hype or Hard Data?
Medscape's new clinician-facing analysis puts intratumoral immunotherapy under scrutiny, asking whether injecting skin tumors dir…
Collagen Supplement Research Carries Major Flaws, Review Finds
Major methodological flaws run through the clinical trials behind oral collagen for skin health, a new review concludes. The anal…
Once-Daily Tapinarof Cream Holds Up Over 60 Weeks in Young Kids' Eczema
Once-daily tapinarof cream showed strong results over 60 weeks in young children with eczema, extending durable, steroid-free top…
Colorimetry Floated as Objective Score for PIH Severity
Bioengineer.org frames colorimetry as the missing numeric yardstick for post-inflammatory hyperpigmentation, with melanin-index r…